Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Adimab's Search Results Lead to Google Ventures

This article was originally published in The Pink Sheet Daily

Executive Summary

Adimab CEO Gerngross wouldn't disclose the amount of Series D money raised, but promised "there will be interactions" between Adimab and parent company Google.

You may also be interested in...



Ablexis' Pharmaceutical Consortium

Ablexis LLC's October 2010 consortium-based alliance with Pfizer Inc. and four other undisclosed "Top 15" drugmakers represents an important new variation in platform-technology deal-making.

Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals

Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.

Financings Of The Fortnight: IPOs Make A Return In Talecris And Omeros Deals

Money continued to flow to big and small biotechs, including nearly a dozen PIPEs or registered direct offerings.

Topics

Latest News
UsernamePublicRestriction

Register

PS068580

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel